Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The lack of an accurate blood biomarker in neuroendocrine tumor (NET) disease impedes effective management.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Oberg K
Authors: Öberg K, Califano A, Strosberg J, Ma S, Pape U,
Keywords: NETest, Meta-analysis, biomarker, in vitro diagnostic, diagnostic, management, NET, AUC, ROC,
Introduction: The tryptophan hydroxylase inhibitor telotristat ethyl (TE) significantly reduced bowel movement (BM) frequency versus placebo (pbo) in patients (pts) with carcinoid syndrome (CS) in the TELESTAR study.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Anthony L, Kulke M, Hörsch D, Bergsland E, Öberg K,
Introduction: Guidelines support an MDT approach to NETs. We present data on the global NET pt perspective regarding MDT care.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Öberg K, Leyden J, Sissons M, Kolarova T, Goldstein G,
Keywords: Multidisciplinary team,
Introduction: We have previously identified five upregulated and four downregulated miRNAs in small intestinal neuroendocrine tumor (SI-NET) tissue. We extended our analysis to serum samples of SI-NET patients to depict miRNAs functions.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Li S
Authors: Li S, Khan M, Caplin M, Öberg K, Meyer T,
Keywords: neuroendocrine tumors, serum miRNA expression, miRNA, target functions ,
Introduction: Somatostatin receptor (SSTR) expression may be used for diagnosis and therapy of lung carcinoids. However, novel targets are requested.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Cui T
Authors: Cui T, Giandomenico V, Öberg K, Pelosi G, Tsolakis A,
Keywords: olfactory receptor 51E1, somatostatin receptor, lung carcinoids, novel target, OctreoScan,